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In the past few years, cognitive enhancing drugs (CEDs) have gained growing interest
and the focus of investigations aimed at exploring their use to potentiate the cognitive
performances of healthy individuals. Most of this exploratory CED-related research
has been performed on young adults. However, CEDs may also help to maintain
optimal brain functioning or compensate for subtle and or subclinical deficits associated
with brain aging or early-stage dementia. In this study, we assessed effects on
resting state brain activity in a group of healthy elderly subjects undergoing acute
administration of modafinil, a wakefulness-promoting agent. To that aim, participants
(n = 24) were investigated with resting state functional Magnetic Resonance Imaging
(rs-fMRI) before and after the administration of a single dose (100 mg) of modafinil.
Effects were compared to age and size-matched placebo group. Rs-fMRI effects were
assessed, employing a graph-based approach and Eigenvector Centrality (EC) analysis,
by taking in account topological changes occurring in functional brain networks. The
main finding of the study is that modafinil promotes enhanced centrality, a measure
of the importance of nodes within functional networks, of the bilateral primary visual
(V1) cortex. EC analysis also revealed that modafinil-treated subjects show increased
functional connectivity between the V1 and specific cerebellar (Crus I, Crus II, VIIIa lobule)
and frontal (right inferior frontal sulcus and left middle frontal gyrus) regions. Present
findings provide functional data supporting the hypothesis that modafinil can modulate
the cortico-cerebellar connectivity of the aging brain.
Keywords: cognitive enhancing drugs, dopamine, aging, resting state fMRI, connectivity, graph theory,
eigenvector centrality
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INTRODUCTION
In the last few years, psychotropic drugs, traditionally employed
to treat a range of neuropsychiatric disorders, have also been
evaluated with the aim to potentiate the cognitive performances
of healthy individuals. The use of cognitive enhancing drugs
(CEDs) is gaining growing attention (Dance, 2016) as these
molecules may be of some help to maintain optimal brain
functioning or even to compensate the subtle and subclinical
deficits associated with brain aging or early-stage dementia.
A rough classification of CEDs encompasses compounds that,
directly or indirectly, influence cognition and behavior by acting
on cholinergic, catecholaminergic, glutamatergic, histaminergic
as well as glucocorticoid-dependent pathways (Fond et al., 2015).
Within the CED subgroup of compounds targeting
dopaminergic and/or adrenergic neurotransmission, modafinil
(trade name Provigil) stands out as a non-amphetamine-like
wake-promoting drug that has been employed to treat excessive
daytime sleepiness associated with narcolepsy, shift-work sleep
disorders, obstructive sleep apnea, and cataplexy (Minzenberg
and Carter, 2008). Off-label use of modafinil has also been
clinically tested to treat cognitive dysfunctions often associated
with the Attention Deficit/Hyperactivity Disorder (ADHD;
Volkow et al., 2009), mood disorders (Goss et al., 2013),
schizophrenia (Dawson et al., 2012), fatigue in multiple sclerosis
(Kraft and Bowen, 2005), and Parkinson’s disease (Tyne et al.,
2010).
Modafinil acts on subcortical structures, namely the thalamus,
hypothalamus, and amygdala to reinforce physiological
mechanisms involved in the activation and maintenance of
wakefulness (Gerrard and Malcolm, 2007). Modafinil exerts its
action by competitively binding to the dopamine transporter
(DAT) as well as by inhibiting norepinephrine uptake, thereby
producing an overall elevation of catecholamine levels and
potentiation of adrenergic neurotransmission (Qu et al., 2008).
Modafinil can also increase extracellular brain levels of serotonin,
glutamate, histamine, and orexin as well as decrease the release
of gamma-amino-butyric acid (Minzenberg and Carter, 2008).
Recent behavioral studies have indicated that modafinil can
enhance cognitive performances in domains like attention,
memory, executive functions, and increase alertness and response
accuracy (Battleday and Brem, 2015). Furthermore, in preclinical
settings, the drug has been shown to promote hippocampal
neurogenesis (Brandt et al., 2014) and synaptic plasticity (Rao
et al., 2007; Tsanov et al., 2010). Overall, this psychostimulant has
been viewed as a CED with lower risks of inducing addiction and
a favorable side effect profile (Malcolm et al., 2002).
Neuroimaging studies have helped to clarify modafinil effects
on functional connectivity across brain network nodes (Esposito
et al., 2013; Cera et al., 2014; Battleday and Brem, 2015). However,
most of these functional Magnetic Resonance Imaging (fMRI)
studies investigated modafinil or dopamine-related CED effects
in young subjects while not much evidence is available on CED
activity on the aging brain.
In this study, with fMRI, we assessed effects on functional
connectivity (FC) evoked by the administration of a single dose
(100 mg) of modafinil in a sample of healthy elderly individuals.
Resting state fMRI (rs-fMRI) effects were also, in parallel, tested
in an age-matched group undergoing placebo treatment.
MATERIALS AND METHODS
Study Subjects
The study was conducted at the Institute of Advanced Biomedical
Technologies (ITAB), a clinical research center of the Chieti-
Pescara University, and involved twenty-four (16 females and
8 males) participants divided into two study groups matched
for age, sex, and education (Table 1). We enrolled subjects (age
range 57–75 years old) with comparable levels of education
(11 ± 3.9 years). Study eligibility was determined after complete
physical and neurological examinations by an expert neurologist.
Moreover, participants were evaluated by careful and thorough
radiological history to exclude unsuitability for MRI scanning.
To determine the global cognitive status, we employed the Mini-
Mental State Examination (MMSE- Folstein et al., 1975), a widely
used test that allows evaluation of orientation, attention, memory,
language, and visual-spatial skills. All the recruited participants
had MMSE ≥ 27 scores. Subjects with past or current psychiatric
disease and neurological deficiencies were excluded. None of the
study participants suffered or was suffering from major illnesses
or had a history of tobacco, alcohol, and/or psychoactive drug
abuse. None of the volunteers was actively smoking at the time of
the study. All the participants were consuming what is considered
a regular intake of 1–2 Italian espresso per day. Participants were
asked to avoid alcohol consumption 12 h before the beginning of
the study and to maintain their usual levels of intake of caffeine.
After providing written informed consent, study participants
received, in a double-blind and randomized fashion, a single-
dose of modafinil (modafinil group, n = 12) or a placebo pill
identical to the drug pill (placebo group, n = 12). All subjects
then underwent two fMRI scans, performed before and 3 h after
drug (or placebo) administration, to achieve a plateau phase in
drug levels in line with the compound pharmacokinetic profile
(Robertson and Hellriegel, 2003). The study followed the tenets of
the Declaration of Helsinki and was approved by the local Ethics
Committee (PROT 2008/09 COET on 10.14.09).
MRI Data Acquisition
Resting state-fMRI Blood oxygen level-dependent (BOLD) data
were subdivided into two runs, lasting 4 min each, followed by
T1- weighted multi-echo MPRAGE sequences for anatomical
reference. The choice of two runs was driven to increase the
TABLE 1 | Demographic variables (gender, age, and years of formal
education) of the total sample, modafinil group, and placebo group,
separately.
Group Number Gender
(males)
Age (means,
years ± SD)
Education
(means,
years ± SD)
Modafinil group 12 12 (4) 66.5 ± 4.66 10.66 ± 4.0
Placebo group 12 12 (4) 66.08 ± 5.21 11.5 ± 4.07
Total sample 24 24 (8) 66.29 ± 4.8 11.08 ± 3.9
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overall reliability and quality of BOLD signals and accommodate
the participant’s request to minimize the discomfort of long MRI
acquisitions. This choice also significantly reduced the impact
of artifacts due to movements. Long BOLD time-series, for
each subject, maximized the statistical power when calculating
Pearson’s correlation coefficient.
Subjects were asked to relax and fix a central point in the
middle of a background screen. Upon rs-fMRI acquisitions,
participants were instructed to stay still, keep their eyes open
on a fixation cross, and do not think about anything in
particular. All images were acquired with an eight-channel
coil. Foam pads positioned around the head were added
to reduce large involuntary movements. BOLD imaging was
performed with a Philips Achieva 3T Scanner (Philips Medical
Systems, Best, The Netherlands) and images acquired with T2∗-
weighted echo planar imaging (EPI) sequence with the following
protocol: TE (echo time) 35 ms, matrix size 64 × 64, FoV
(field of view) 256 mm, in-plane voxel size 4 × 4 mm, flip
angle 75◦, slice thickness 4 mm and no gaps. 140 functional
volumes of 30 axial slices were acquired per run with a
volume TR (repetition time) of 1671 ms. A high-resolution
structural volume was acquired at the end of the two rs-fMRI
runs through a 3D magnetization prepared rapid gradient
echo (MPRAGE) sequence employing the following parameters:
sagittal, acquisition matrix = 256 × 256, FoV 256 mm, slice
thickness 1 mm, no gaps, in-plane voxel size 1 mm × 1 mm, flip
angle 12◦, TR= 9.7 ms and TE= 4 ms.
Data Processing and Statistical Analysis
fMRI data were pre-processed by applying corrections for
head motion, removal of non-brain voxels and slice-timing
corrections (performed using FSL: FMRIB’s Software Library)1.
Several sources of physiological variance were mitigated from
each subject time-series. Six parameters of realignment and their
derivatives, the first five eigenvectors of the PCA decomposition
of the EPI time course, averaged over cerebrospinal fluid (CSF)
and white matter (WM), were regressed out, following the
CompCor approach for physiological noise removal (Behzadi
et al., 2007). Head motion estimation parameters were used
to derive frame-wise displacement (FD). Time points with
high FD were replaced by a cubic-spline interpolation (Power
et al., 2012). Data were then demeaned, de-trended and band-
pass filtered in the frequency range of 0.01–0.1 Hz. A two-
step registration process was performed for group analysis.
fMRI data were transformed, linearly, from functional space
to individual subject structural space using the FMRIB’s
Linear Registration Tool (FLIRT) and then, non-linearly, to a
standard space (Montreal Neurological Institute standard map –
MNI 152) using Advanced Normalization Tools (ANTs; Penn
Image Computing & Science Lab)2. Finally, data were spatially
smoothed (5 mm × 5 mm × 5 mm full-width half-maximum
Gaussian kernel). At the end of the pre-processing, immediately
before the registration to the standard space, two fMRI datasets
1www.fmrib.ox.ac.uk/fsl
2http://www.picsl.upenn.edu/ANTS/
for each subject were registered one to the other and merged after
temporal mean removal and variance normalization.
Network Analysis
To investigate changes in functional brain network organization
induced by drug administration, we modeled resting state FC
as a complex network (Caldarelli, 2007). Network analysis
investigates node centrality. However, alternative definitions are
available to describe the concept. Eigenvector Centrality (EC) was
chosen as a topological metric to disclose brain nodes that were
functionally connected to other highly functionally connected
nodes (Rubinov and Sporns, 2010). Estimation of the degree of
centrality was indirectly included as a parameter to calculate the
threshold based on Erdos–Renyi entropy.
A functional connection between two brain areas was
considered as an undirected (i.e., without a specific orientation)
and weighted (i.e., with a value associated with the connection)
graph link. The weight used for each link is the correlation
coefficient that is calculated taking into consideration the
time-series associated with the two areas (Gili et al., 2013).
R-squared correlation coefficients were considered as similarity
indices to account for correlations that result from neural-
mediated, temporally and spatially heterogeneous, hemodynamic
mechanisms (Goelman et al., 2014). It should be taking into
account that this approach may potentially lead to some loss
of information. In fact, positive and negative correlations, when
carrying the same absolute values, refer to the same amount
of information regarding connectivity strength. As we evaluated
undirected weighted graphs, the phase-shift between time-series
is, therefore, lacking information on the positive or negative
value of the correlation. For each subject, the square value of
the N × N correlation matrix R was calculated (N being the
number of voxels of the gray matter considered) and a threshold
applied to ensure that the Erdos–Renyi entropy of the network
(S) was equal to 2 across subjects (Hayasaka and Laurienti, 2010).
S= 2 corresponded to a specific correlation value for each subject,
thereby leading to the same amount of surviving matrix elements
after threshold. This approach maximizes the consistency of
results. The applied threshold is very conservative and takes into
account a restricted (0.4–0.5) range of correlation coefficients
that are associated with S = 2. The stability and robustness of
functional brain networks as function of S, when large values
(S= 1, 1.5, 2) are employed, has been previously shown to reliably
occur in healthy subjects (Hayasaka and Laurienti, 2010; Gili
et al., 2013) or stroke patients (Gili et al., 2016).
S was calculated as the ratio between the logarithm of the total
number of nodes and the logarithm of the normalized degree
of the network (Watts and Strogatz, 1998). A generalization
of the EC was then calculated from the resulting matrix
(Newman, 2004). EC assigns relative scores to all nodes in the
network assuming that connections to highly scoring nodes
(highly connected nodes) contribute more to each score than
equal connections to low-scoring nodes (poorly connected
nodes), thereby shifting the ranking procedure to a multi-
level perspective. It must be added that EC is based on the
eigenvector decomposition of similarity matrices. Since the
existence of the largest eigenvalue of a matrix is guaranteed
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in case of a semidefinite positive symmetric matrix (Perron–
Frobenius theorem), the choice of taking in account the square
of correlation coefficients, which can assume both positive and
negative values, is appropriate. EC has been proven to be robust,
reliable, not computationally demanding, and, unlike other
measures, able to capture aspects of centrality that encompass
global features of the graph. Other centrality measures were not
considered for either computational reasons (betweenness) or
because of the lack of information added (laplacian, katz).
The resulting centrality maps were then transformed (van
Albada and Robinson, 2007) to ensure that they obey to
a Gaussian normal distribution as required for subsequent
statistical testing. To examine the influence of modafinil on
the group level statistics, paired t-tests were performed to
identify areas in which centrality varied significantly with the
neurophysiological state. The analysis was corrected for subject
gender, including it as a nuisance variable. Changes of EC
(Nichols and Holmes, 2002) were identified from a permutation-
based non-parametric within-subject paired analysis (FSL
randomize). This analysis modeled the interaction of the effect
of treatment, namely baseline pre-treatment (B) and end of
treatment (E), and the effect of condition, namely D (drug)
and P (placebo). The interaction is described by the contrast
(ED–BD) – (EP–BP). Positive and negative interaction effects
were examined. The results were subjected to threshold-free
cluster enhancement (Smith and Nichols, 2009) and family wise
error (FWE) corrected for multiple comparisons by permutation
testing using a significance level of p< 0.05.
r2 ROI-Based Analysis
To elicit the origin of centrality changes, we investigated patterns
of changes of brain voxels r2 with respect to one specific Region
of Interest (ROI). EC reports the strength of voxel-to-voxel
connections but also reflects and captures the global features of
the graph (Caldarelli, 2007). Accurate EC estimation of a whole
graph G = (V, E) can be nevertheless achieved by appropriate
tuning of the weights of subsets of the total links (Nicosia et al.,
2012). The only constraint of this approach is that N links must
belong to a subset E′⊆E as such that, for every node i∈V, there is a
link l ∈ E′ pointing to i (Nicosia et al., 2012). Since, in the present
study, we have identified a change of EC in just one cluster, it
is possible to proceed with the investigation of the dependence
of this change by looking at changes in connectivity between the
cluster and its connections. Structured in this way, the procedure
does not produce loss of generality.
The primary visual cortex (V1) or Brodmann Area 17 (BA17)
was chosen accordingly to the results of network analysis.
BA17 ROI was defined in MNI 152 space from the preceding
analysis. R2 maps for each subject were obtained by squaring the
correlation coefficient calculated between the average time series
from the ROI and all the voxels of the brain. The resulting images
were combined in a not- parametric permutation inference
by FSL randomize (Nichols and Holmes, 2002); within-subject
paired t-tests were used to assess increase of connectivity as
consequence of modafinil action, controlled for the placebo
condition as described in the network analysis section. Changes
were considered statistically significant at p < 0.001 voxel level
uncorrected and p < 0.05 cluster level FWE corrected. Gender
was included as a nuisance variable.
RESULTS
The main results of this study relate to centrality and functional
network changes evoked by acute administration of modafinil.
Centrality Changes Induced by Acute
Administration of Modafinil: Effects on
the Primary Visual Cortex
Eigenvector centrality maps were calculated on networks
composed of ∼30,000 gray matter voxels. The threshold was
chosen by setting S = 2 in each connectivity matrix. This
threshold conferred small-worldness to the networks and
produced sparse matrices whose non-zero elements were 15%
of the total entries. Paired t-tests were performed across the
study group [(ED-BD) > (EP-BP)] to identify areas where EC
varied significantly with the neurophysiological status. In the
modafinil group, in the post-drug period, we found an increase of
centrality that occurred bilaterally in the BA17 (Figure 1), thereby
suggesting an increase of the FC of the visual cortex with other
brain regions due to drug action. No significant changes were
found in the opposite contrast [(BD-ED) > (BP-EP)].
Functional Network Changes Induced by
Acute Administration of Modafinil
To further investigate these modafinil-driven centrality changes,
ROI-based FC analysis was performed using BA17 as resulted
from the group statistics of EC maps. FC analysis revealed
connectivity increase within the cerebellar Crus I, Crus II areas,
and VIIIa lobule, the right inferior frontal sulcus (IFS), and the
left middle frontal gyrus (MFG). Paired t-test of the pre- and
post-drug imaging data showed increased connectivity of BA17
with these cerebellar and frontal lobe areas, thereby supporting
a drug effect in the modulation of cortical and cerebellar
connectivity.
The V1 showed a specific pattern of increased connectivity
within the left [−29, −76, −30] and right [21, −79, −30]
cerebellar Crus I, the left [−23, −84, −34] and right
[17, −80, −34] cerebellar Crus II, the left [−27, −57, −56] and
right [34, −53, −50] cerebellar VIIIa, the right IFS [44, 46, −8],
and the left MFG [−29, 38, 23] (Figure 2 and Table 2).
DISCUSSION
In this study, we examined acute rs-fMRI effects on sub-regional
FC evoked by the administration of a single dose of modafinil
in a study group composed of healthy elderly subjects. Rs-fMRI
is widely employed to investigate the activity of functional brain
networks (Friston et al., 1993). Rs-fMRI is based on fluctuations
of BOLD signals that temporally correlate with the spontaneous
neuronal activity occurring in spatially distant brain regions that
are not, necessarily, structurally related. Functional correlates
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FIGURE 1 | Eigenvector centrality (EC) changes induced by acute administration of modafinil or placebo. The image depicts maps of a paired t-tests
obtained from the contrast (drug effect > drug baseline) > (placebo effect > placebo baseline) and considering the gender as a variable of not interest. A significant
EC increase was observed in the primary visual cortex bilaterally (BA17) in the modafinil study group. Depicted clusters survived correction for multiple comparisons
across space with FWE correction at P values < 0.05. Coordinates refer to MNI space.
of rs-fMRI are assumed to refer to self-referential thoughts,
awareness of sensory inputs and dynamic environmental changes
(D’Argembeau et al., 2005; He, 2013).
In the study, FC data were analyzed with a graph-based
approach and algorithms set to highlight gray matter nodes
based on their connectivity strength. This correlation-based FC
analysis identifies and unravels, in a quantitative way, statistical
associations between changes in BOLD signals occurring in
cortical regions.
In the modafinil-treated group, we found, in the post-drug
period, greater centrality in the bilateral primary visual cortex
[BA17], the brain region highly specialized for processing visual
information.
Functional connectivity analysis also revealed a drug-related
involvement of the cerebellum. Modafinil administration was, in
fact, found to be associated with increased connectivity between
the V1 and the cerebellar Crus I, Crus II, and VIIIa lobule.
Additional major FC changes were found in V1 connections with
the right IFS and the left MFG of the frontal cortex.
These frontal areas are known to modulate attention levels
and some core processes associated with executive functions,
and, specifically, inhibitory control and working memory (WM).
These functions depend on each other and co-activate frontal
areas along with the posterior visual cortex to re-orient attention
toward visual stimuli and also enhance cognitive efficiency.
Data on behavioral effects of modafinil administration in
our study group are missing and, at this stage, we can only
provide theoretical speculations for the functional correlates of
the regional activations that we have found to be promoted by
the drug.
A conceptual framework for the FC effects on the V1 may take
into account that rs-fMRI study participants, even though scans
are performed in “resting conditions,” are nevertheless asked to
employ significant levels of visual alertness. Subjects are asked
to keep their eyes open, look at a fixation cross, stay still, and
retain these commands throughout the whole scanning period.
Thus, to fulfill rs-fMRI requirements, subjects need to activate
voluntary inhibition of movements, maintain visual attention as
well as engage the WM.
Thus, within this framework, it is conceivable that the
modafinil-driven increased FC we have found to occur between
the V1 and some prefrontal areas reflects the active involvement
of visual-, attention-, and WM-dependent networks that were set
in motion by the rs-fMRI protocol and, possibly, boosted by the
drug.
The V1 effects should be considered in relation to the
main function of this brain region. The V1 is crucial to allow
visual perception (Boly et al., 2007), a process that combines
a set of “bottom-up” activities that are stimuli- and sensory-
driven with a “top-down” information flow originating from
the associative regions of higher order. The top-down process
influences patterns of recognition, thereby favoring dynamic
improving or updating of the sensorial information flow. Thus,
the process favors the orientation of selective attention to relevant
stimuli, thereby favoring a filtering activity that prevents WM
overload (Gazzaley et al., 2005).
As for the modafinil-driven effects on the frontal cortex,
several studies have indicated that the MFG and the neighboring
inferior frontal cortex (IFC) act to filter out noise and irrelevant
stimuli, thereby re-directing attention to achieve accurate task
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FIGURE 2 | Seed based r2 connectivity analysis of the BA17 region in the modafinil and placebo groups. The image depicts maps of a paired t-tests
calculated for the contrast (drug effect > drug baseline) > (placebo effect > placebo baseline) and considering the gender as a variable of not interest. Significant
increases of r2 were observed in the left and right cerebellar Crus I, the left and right cerebellar Crus II, the left and right cerebellar VIIIa, the right IFS and the left
MFG. Depicted clusters survived correction for multiple comparisons across space with FWE correction at P values < 0.05. Coordinates refer to MNI space.
performance (Hopfinger et al., 2000; Corbetta and Shulman,
2002; Badre and Wagner, 2005). Moreover, the right IFS, a key
node of IFC, has been associated with WM-related processes
like the activation of inhibitory control (Aron et al., 2004) and
selective attention (Dodds et al., 2011). These functions work
to complement what described for the V1, thereby suggesting
an overall scenario in which modafinil may act to improve
interference control.
Our FC results also indicate a major effect exerted by modafinil
on the cerebellum resting activity. The cerebellum is emerging
as a crucial modulator of cognition as evidence indicates that
cerebellar projections target multiple associative areas in the
parietal and prefrontal cortex (Stoodley and Schmahmann, 2009).
Our rs-fMRI data indicate the occurrence of enhanced
modafinil-driven FC between the V1 and the cerebellar Crus I
and II. These areas are involved in modulating attention and
spatial processing as well as WM encoding and maintenance (E
et al., 2014). We also found increased FC between the V1 and
the VIIIa lobule, a cerebellar region associated with sensorimotor
processing. Previous results have indicated that prefrontal areas,
Crus I/II, VIII cerebellar lobule are part of a cortico-cerebellar
closed-loop (Salmi et al., 2010 ).
Of note, despite the large evidence in preclinical and clinical
settings showing modafinil-driven FC effects on the thalamus,
TABLE 2 | Peak voxel coordinates of regions showing increased functional
connectivity with the BA17 due to drug effect.
Brain region Cluster size
(vox)
Voxel (x, y, z) Voxel (T)
Crus I of cerebellum (R) 2507 (21, −79, −30) 4.78
Crus II of cerebellum (R) (17, −80, −34) 4.88
Crus I of cerebellum (L) 1251 (−29, −76, −30) 5.53
Crus II of cerebellum (L) (−23, −84, −34) 4.64
Lobule VIIIa of cerebellum (R) 661 (34, −53, −50) 4.46
Lobule VIIIa of cerebellum (L) 545 (−27, −57, −56) 4.28
Inferior frontal sulcus (R) 460 (44, 46, −8) 4.43
Middle frontal gyrus (L) 450 (−29, 38, 23) 4.99
Coordinates are reported in MNI space (mm). The voxel size was
1 mm × 1 mm × 1 mm and regions are grouped according to the cluster
to which they belong. L, Left; R, right; BA, Brodmann area.
our EC analysis failed to report a great drug-related enhanced
centrality for this region (Urbano et al., 2007; Minzenberg and
Carter, 2008). Given that most of the studies have shown drug-
related effects in young subjects, we can only speculate that
the lack of major thalamic involvement that we found in our
elderly sample may indicate lower sensitivity to modafinil of this
subcortical region upon aging.
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The net behavioral correlates of modafinil-driven modulation
of network activities are largely unknown and likely to
be complex. Preclinical evidence suggests potential beneficial
effects. In theory, modafinil-driven FC changes may lead
to enhanced experience-dependent synaptic plasticity and
neurogenesis as well as behavioral and cognitive benefits
(Minzenberg and Carter, 2008). The notion is supported by
preclinical evidence showing that modafinil, through increased
dopaminergic and noradrenergic transmission, promotes adult
neurogenesis, especially within the hippocampus (Brandt et al.,
2014). Furthermore, in preclinical models, modafinil has been
shown to improve spatial learning and fear conditioning,
inhibitory control, WM functioning, and sustained attention
(Morgan et al., 2007; Shuman et al., 2009; Tsanov et al., 2010).
Our studies provide some FC evidence that corroborates the
hypothesis that modafinil may interfere with some of these
cognitive domains.
CONCLUSION
The potential therapeutic implication of modafinil use in the
elderly can especially be envisioned when considering aging- or
Alzheimer’s disease (AD)-dependent cognitive deficits.
Upon brain aging, cognitive deficiency can result from failure
of inhibitory processes and the dysfunctional interplay between
the WM and the attentional systems (Luis et al., 2015). This
dysfunction can result in an overall reduced activity of filtering
relevant information while increasing the production of noise
overflow (Luis et al., 2015). A similar deficit in cognitive control
has been found to occur in mild cognitive impairment (MCI) or
early-stage dementia patients. Thus, on a speculative note, the
modafinil-driven FC effects we are reporting to occur in areas
that are controlling attention and inhibitory control may help to
counteract deficits of the aging brain as well as in the brain of MCI
or AD patients.
Interestingly, recent data indicate that AD-related
neurodegeneration is present, beyond the cortex, also in the Crus
I and II cerebellar regions (Guo et al., 2016). In that respect, it is
conceivable that the modafinil FC effects we have found in these
cerebellar areas may be of some help and exert a compensatory
role.
There are some limitations of the present study. One
limitation relates to the acute nature of our pharmacological
intervention as chronic administration of modafinil may produce
different activation patterns. An additional limit of the study
concerns the lack of investigation of behavioral effects evoked
by the acute administration of modafinil. Furthermore, in the
age of precision medicine, further information is warranted on
CED and modafinil activity in relation to factors such as genetic
background, psychosocial features, as well as baseline levels of
performance, a set of critical elements that can very differently
shape drug responses in each individual.
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